Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    weill | Open Studies | "Liver Cirrhosis, Biliary"
Show Display Options
Rank Status Study
1 Recruiting Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis;   PBC
Interventions: Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic Acid

Indicates status has not been verified in more than two years